Authors
Loading...
Prospective observational study shows 70% retention in baricitinib-treated rheumatoid arthritis patients, indicating effective outcomes and predictors of treatment discontinuation.
Kaneko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: